Biological fungicides and biological seed treatments will be among the products set to be manufactured at the plant, where BASF is also planning to produce the main building block of a novel insecticide derived from a fungal strain.
Commissioning of the plant, which represents a high double-digit million euro investment, is planned for the second half of 2025. It will use microorganisms to convert renewable raw materials such as glucose into the desired products - a process known as fermentation.
See also: How soil biology can ward off pests - but should we buy it in?
"We see a growing demand for biological crop protection products," says Marko Grozdanovic, senior vice president, global strategic marketing at BASF Agricultural Solutions.
"In addition, fermentation is a very flexible technology that will allow us to bring more innovative biotechnology-derived products to the market in the future."